Therefore, further characterization of the complex regulatory actions by which TGFβ signaling mediates its functions during normal lymphopoiesis and in its malignant counterparts should be the focus of future research in order to improve our understanding of this signaling pathway, as well as to develop novel treatment approaches in BCP-ALL. This evidence concerns the gene TGFB1 and acute lymphoblastic leukemia.